Documentos relacionados

1. Innovative thiosemicarbazones that induce multi-modal mechanisms to down-regulate estrogen-, progesterone-, androgen- and prolactin-receptors in breast cancer.
2. Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer.
3. Resistance to hormone therapy in breast cancer cells promotes autophagy and EGFR signaling pathway.
4. Effects of Combined Pentadecanoic Acid and Tamoxifen Treatment on Tamoxifen Resistance in MCF-7/SC Breast Cancer Cells.
5. PTEN promoter methylation predicts 10-year prognosis in hormone receptor-positive early breast cancer patients who received adjuvant tamoxifen endocrine therapy.
6. EGFR inhibition reverses epithelial­mesenchymal transition, and decreases tamoxifen resistance via Snail and Twist downregulation in breast cancer cells.
7. Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial.
8. Tamoxifen induced hands deformities.
9. Characterization of Breast Cancer Aggressiveness by Cell Mechanics.
10. Effects of chemically EGFR targeting on non-targeted physical cell behaviors in 2D and 3D microfluidic cultures of invasive and non-invasive breast cancer cell lines.